These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28903994)

  • 1. The level of heparin-induced antibodies in correlation with the result of the flow cytometric functional assay in the patients with suspected HIT.
    Maličev E; Maček Kvanka M; Klemenc P; Rožman P
    J Clin Pathol; 2017 Dec; 70(12):1084-1087. PubMed ID: 28903994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: ELISA optical density value and 4T score in correlation with panel donor platelets activation in functional flow cytometric assay.
    Železnik K; Rožman P; Kocjan E; Maličev E
    Blood Transfus; 2021 Jan; 19(1):77-84. PubMed ID: 33085589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
    Whitlatch NL; Perry SL; Ortel TL
    Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.
    Eekels JJM; Althaus K; Bakchoul T; Kroll H; Kiefel V; Nazy I; Lee LS; Sachs U; Warkentin TE; Greinacher A
    J Thromb Haemost; 2019 Mar; 17(3):525-531. PubMed ID: 30640980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
    Raschke RA; Curry SC; Warkentin TE; Gerkin RD
    Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
    J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.
    Althaus K; Strobel U; Warkentin TE; Greinacher A
    Thromb Res; 2011 Sep; 128(3):256-60. PubMed ID: 21620439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
    Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
    Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.
    Pearson MA; Nadeau C; Blais N
    Clin Appl Thromb Hemost; 2014 May; 20(4):349-54. PubMed ID: 24288385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia.
    Greinacher A; Fürll B; Selleng S
    Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
    Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
    Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
    Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
    J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study.
    Levine RL; Hergenroeder GW; Francis JL; Miller CC; Hursting MJ
    J Thromb Thrombolysis; 2010 Aug; 30(2):142-8. PubMed ID: 19911252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
    Kannan M; Ahmad S; Ahmad F; Kale S; Hoppensteadt DA; Fareed J; Saxena R
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):487-90. PubMed ID: 16175007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.